药明合联拟按每股58.85港元配股 最多净筹约13.01亿港元

Core Viewpoint - WuXi AppTec (02268) has entered into a placement agreement to issue up to 22.277 million shares at a price of HKD 58.85 per share, aiming to raise approximately HKD 1.311 billion, with net proceeds expected to be around HKD 1.301 billion [1] Group 1 - The placement is conditional and will be conducted through a placement agent to at least six independent third-party investors [1] - Approximately 90% of the proceeds will be used to expand the company's service capabilities and production capacity, particularly in bioconjugates, active pharmaceutical ingredients, and commercial production [1] - The remaining 10% of the funds will be allocated for working capital needs and general corporate purposes [1]